In addition, the pharmacology with the active factors was mostly uncharacterized, and affirmation of SCB use was hindered by a lack of acknowledged biomarkers. These awareness gaps prompted experts across multiple disciplines to promptly (1) monitor, establish and quantify with chromatography/mass spectrometry the at any time-transforming contents